These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [The prostacyclin-thromboxane A2 system in ischemic heart disease]. Pavlov NA Sov Med; 1987; (2):36-9. PubMed ID: 3554549 [No Abstract] [Full Text] [Related]
15. [Platelets and myocardial ischemia]. Zhao ZQ; Zang YM Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):36-9. PubMed ID: 2672308 [No Abstract] [Full Text] [Related]
16. Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin. Schrör K; Grodzinska L; Darius H Thromb Res; 1981 Jul 1-15; 23(1-2):59-67. PubMed ID: 6795756 [No Abstract] [Full Text] [Related]
17. Pharmacological interactions between prostacyclin and thromboxanes. Whittle BJ; Moncada S Br Med Bull; 1983 Jul; 39(3):232-8. PubMed ID: 6313114 [No Abstract] [Full Text] [Related]
18. [Stenocardia. Thromboxane A2 and prostacyclin]. Panchenko EP Kardiologiia; 1986 Jul; 26(7):109-16. PubMed ID: 3093749 [No Abstract] [Full Text] [Related]
19. [Prostaglandins and related substances: metabolic pathways]. Murota S; Morita I Nihon Rinsho; 1985 Mar; 43(3):480-8. PubMed ID: 3925196 [No Abstract] [Full Text] [Related]
20. The platelet-perfused in-vitro heart: an alternative model for studying the role of endogenous prostacyclin and thromboxane in control of coronary perfusion. Köhler P; Schrör K Basic Res Cardiol; 1981; 76(5):463-7. PubMed ID: 7030300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]